NCT06549595 2026-03-18
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
AstraZeneca
Phase 3 Recruiting
AstraZeneca
Genmab
Genmab
Novartis
Sun Yat-sen University
Second Affiliated Hospital of Nanchang University